Abstract
Implantable cardioverter defibrillators (ICD) are highly effective in the identification and termination of malignant ventricular tachycardia and fibrillation. It is anticipated that the number of patients receiving this device will increase because of major advancements in technology and the results of prospective controlled clinical trials. Major life changes occur after implantation of the device. Continued research is needed to identify concerns and needs of patients with ICDs and their families. Specific interventions must be tested to determine efficacy. Nurses must be able to provide education and psychologic support to assist patients in their successful transition to home.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.